Study Design. A retrospective review. Objective. We sought to use data from 4 tertiary medical centers to explore surgical, medical, and demographic factors that influence survival within the first 90 days following surgery for spinal metastases. Summary of Background Data. Over the last 2 decades, patients with spinal metastases have become more likely to receive surgical intervention. The impact of surgical intervention and its potential benefits must be weighed against the risk of complications and peri-operative mortality. Risk factors that elevate the risk of mortality in the acute postoperative period are not well understood. Methods. All records of patients who underwent surgery for metastatic spinal disease at 1 of 4 academic medical centers in New England from 2007 to 2013 were obtained. Patient demographics, tumor characteristics, medical comorbidities, nutritional and functional status, as well as surgical variables were abstracted. Mortality was assessed for patients at 30 and 90 days following the procedure. Factors predictive of survival were assessed using bivariate logistic regression. Those factors with P values < 0.20 in the bivariate assessment were included in a final multivariable model that adjusted for confounders. Results. Between 2007 and 2013, 318 patients received surgical intervention for metastatic disease involving the spine.
A s advances have been made in medical management, anesthesia techniques, and surgical approaches over the last 2 decades, the incidence of operative intervention for the treatment of spinal metastases has risen dramatically. [1] [2] [3] [4] [5] [6] [7] [8] [9] In most instances, surgical treatment for spinal metastases has been shown to be superior to nonoperative measures, 1,2 with several works reporting significant advantages for physical function, cognitive performance, and possibly survival. 2, 10 Operative intervention for spinal metastases is complex, however, and patients may be at an elevated risk of postoperative morbidity and mortality. 8, 9 Indeed, recent studies evaluating peri-operative outcomes following surgery for spinal metastases have encountered complication rates exceeding 20% and shortterm mortality has been estimated in the range of 7% to 15%. 1, 6, 8, 9, 10 In the event of a postoperative complication, the potential benefits of surgical intervention may be obviated and a more precipitous clinical decline could transpire. 1, 9, 11 Appreciating the importance of patient selection in ensuring optimal outcomes, a number of studies have attempted to define factors that help identify patients at an elevated risk of mortality in the peri-operative period. 3, 5, 8, 10, [12] [13] [14] From the , were developed before the era of modern spine surgical instrumentation and radiotherapy techniques and were based on small cohorts of patients treated at single centers with limited capacity for generalization. In fact, some studies have found that the Tokuhashi score was not a significant predictor of patient survival at all, 13 while others have found its predictive capacity is in the range of only 60%. 5, 8 Recognizing these limitations in the current literature, we sought to more critically investigate factors that may influence survival in the acute postoperative period (e.g., up to 90 days following surgery) following surgery for spinal metastases. This study was conducted using patient-centered data obtained from the surgical registers of 4 major academic medical centers between 2007 and 2013. The relatively large sample, multicenter design and the number of years over which this study was conducted may render our results more translatable to the average patient receiving surgical intervention for spinal metastases in the United States today.
METHODS
The surgical registers from 4 participating tertiary academic medical centers were queried to identify all adult patients (age 18 yrs and over) who underwent a surgical intervention for the treatment of spinal metastases. Patients with spinal metastases who only received percutaneous surgical procedures, including vertebroplasty/kyphoplasty and/or biopsy alone, as well as those treated nonoperatively were excluded from further review. Individuals who received surgery for primary spinal tumors and pediatric patients (age 17 yrs and younger) were likewise ineligible for inclusion in this analysis.
Cases selected for inclusion were manually reviewed to confirm eligibility and subsequently abstracted to obtain demographic data, including age at the time of presentation, race/ethnicity, and sex. Medical comorbidities, categorized using Charlson criteria, 17 body mass index (BMI), primary tumor diagnosis, the number of metastases, site(s) of metastases, number of visceral metastases (if present), pre-operative serum albumin, and ambulatory status before surgical intervention were also recorded. Pre-operative serum albumin and ambulatory status have previously been postulated to serve as proxies for nutritional status and physical function, respectively. 1, 2, 9, 11, 18 Low serum albumin (<3.0-3.5 g/dL) has long been known to influence wound healing in orthopedic interventions 18 and was recently shown to impact outcomes following spinal arthrodesis. 11 Surgical data included the hospital site where surgery was performed as well as the specific surgical intervention and whether postoperative chemotherapy and/or radiation were administered. Patients were censored for the development of complications within 30 days of surgery, including hematoma/seroma/impaired wound healing, surgical site infection, hardware failure/malpositioning, venous thromboembolic disease, and new postoperative neurologic deficit. Survival was assessed at 30 and 90 days following the date of the index surgical procedure.
Patient survival at 30 and 90 days following surgery were considered the outcomes of interest. Age, sex, number of Charlson comorbidities, BMI, pre-operative serum albumin, pre-operative ambulatory status, primary tumor diagnosis, and the type of surgery were considered predictor variables. Age was analyzed as a continuous variable, while all others were treated categorically. BMI was dichotomized into those who were underweight (BMI <18.5 kg/m 2 ) as compared with those with BMI !18.5 kg/m 2 . Pre-operative serum albumin was classified as normal (!3.5 g/dL) or low (<3.5 g/dL). Ambulatory status was defined as normal or impaired, with the impaired class including patients who required an ambulatory aid (e.g., cane, walker, crutches, or wheelchair) or were nonambulatory/bed-ridden. The surgical intervention was classified as stand-alone decompression if no spinal arthrodesis was performed and no instrumentation was implanted. The surgery was considered a decompression with spinal reconstruction if spinal instrumentation and/or arthrodesis were performed.
Initial bivariate comparisons were conducted between the predictor variables and survival at 30 and 90 days, with separate analyses performed for each time-point. Bivariate comparisons were performed using Chi-square testing for categorical variables and logistic regression analysis. Linear regression was performed for continuous predictors. Those predictor variables that maintained P < 0.2 in initial bivariate testing were subsequently entered into a multivariable logistic regression analysis that controlled for potential confounders in the model. Only those factors that demonstrated P values < 0.05 with effect sizes and 95% confidence intervals (95% CIs) exclusive of 1.0 following final multivariable logistic modeling were considered statistically significant independent predictors of survival. The discriminatory capacity of the final models, as well as model calibration, were assessed using the c-statistic and Hosmer-Lemeshow Goodness of Fit test. All testing was performed using STATA software version 13.0 (STATA Corporation, College Station, TX). Investigational review board approval was obtained before the start of this investigation.
RESULTS
Between 2007 and 2013, 318 patients were identified who received a surgical intervention for the treatment of spinal metastases at 1 of the 4 academic centers participating in this study. The majority of patients were male (n ¼ 185, 58%) and of white race (n ¼ 294, 90%, Table 1 ). The average age at the time of presentation was 60.2 years (SD 13.2) and mean BMI was 26.6 kg/m 2 (SD 6.2). Thirteen patients (4%)
were considered underweight on the basis of their BMI score. Lung cancer was the most common primary tumor diagnosis (n ¼ 52, 16%), followed by breast cancer (n ¼ 42, 13%) and lymphoma/myeloma (n ¼ 39, 12%). Thirty-two percent (n ¼ 101) of the cohort had 3 or more Charlson comorbidities. Sixty-two percent (n ¼ 196) demonstrated impaired ambulatory status at the time of presentation and 128 (42%) had low pre-operative serum albumin levels. Most patients (n ¼ 262, 82%) underwent a decompression procedure with spinal reconstruction, while the remainder received a stand-alone spinal decompression. Postoperative chemotherapy and radiation were administered to 53% (n ¼ 167) and 55% (n ¼ 176) of the cohort, respectively. Thirty-three percent (n ¼ 105) of the sample sustained 1 or more postoperative complications. Twenty-nine patients (9%) died within the first 30 days of surgery and 85 (27%) had died by 90 days following surgery. Forty-one percent of those who died within the first 30 days of surgery had sustained complications and a comparable percentage (42%) was appreciated among those who had died by the 90-day time-point.
In total, there were 307 patients with sufficient data to allow for full evaluation using regression tests. Primary cancer diagnosis, pre-operative ambulatory status, preoperative serum albumin, the type of surgical procedure, and BMI all met the criteria for inclusion in the multivariable models for survival at 30-and 90 days based on performance in bivariate analysis ( Table 2 ). The development of postoperative complications was not significantly associated with survival in unadjusted analysis (P ¼ 0.32). Due to all patients with breast cancer surviving for a period greater than 30 days, this variable could not be included in the logistic models as an independent predictor, but rather had to be considered in the group of patients with tumor diagnoses other than lung cancer or lymphoma/myeloma (Appendix, http://links.lww.com/BRS/B58). The strongest associations between risk factors and survival in bivariate analysis were appreciated for lung cancer ( Figure 1 ) and underweight BMI, which were both associated with a decreased likelihood of survival. Pre-operative serum albumin ( Figure 2 ) levels !3.5 g/dL demonstrated strong correlation with an increased chance of survival at both 30 and 90 days.
The results of multivariable logistic regression analysis for 30-day survival revealed that pre-operative serum albumin !3.5 g/dL was the strongest predictor of survival (odds ratio [OR] 9.0; 95% CI 3.1-26.6; P < 0.001), followed by normal ambulatory status at the time of surgery (OR 6.8; 95% CI 1.5-30.7; P ¼ 0.01) and decompression with spinal reconstruction (OR 2.8; 95% CI 1.03-7.8; P ¼ 0.04; Table 3 ). In addition, an underweight BMI at the time of surgery decreased the odds of survival by 82% (OR 0.18; 95% CI 0.04-0.78; P ¼ 0.02). There was no statistically significant evidence of poor calibration (P ¼ 0.98) and the final model explained 85% of the variation in 30-day survival.
Similar findings were encountered among the predictors of survival at 90 days, although underweight BMI at the time of surgery was no longer a significant risk factor (Table 4) . Although primary tumor diagnosis did not significantly predict survival at 30 days following surgery, it did play a significant role regarding survival at 90 days. Here, as compared with the referent (Other Tumor Diagnosis), patients with lung cancer metastases had a 64% reduction in the odds of survival (OR 0.36; 95% CI 0.18-0.72; P ¼ 0.004), while those with lymphoma/myeloma had more than a 4-fold increase in odds (OR 4.5; 95% CI 1.4-14.5; P ¼ 0.01). The final model for 90-day survival showed no statistical evidence of poor calibration (P ¼ 0.80) and explained 76% of the extant variation in this variable.
DISCUSSION
In the last 20 years, spine surgeons have become more enthusiastic about offering operative intervention to patients with symptomatic spinal metastases. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] 13, 14, 15, 19, 20 Several studies have indicated that surgery is more advantageous than nonoperative measures in terms of functional outcome, pain control, and preservation of ambulatory capacity. 1, 2, 8, 9 Invariably, not all patients with spinal metastases can benefit from a surgical procedure, especially as such interventions may be physiologically taxing to oncology patients and are known to carry moderately high rates of postoperative morbidity. 1, 6, 8, 9, 10 Indeed, in the event of a postoperative complication, a patient can experience a precipitous deterioration in pre-operative function and may even be at a higher risk of premature mortality. In this context, it would be useful to spine surgeons, patients, and their families to understand pre-operative risk factors that may portend longer survival versus an unacceptably high risk of mortality in the peri-operative period. Several studies have shown that existing grading scales and classification schemes, including the popular Tokuhashi and Tomita scores, do not reliably predict patient survival following surgery for spinal metastases. 5, 8, 13 We sought to employ the surgical registries of 4 academic medical centers with substantial experience in the care of patients with spinal metastases to evaluate potential predictors for survival within the acute postoperative period (e.g., 90 days following surgery). The 318 patients included in our analysis represent 1 of the largest cohorts assembled for the consideration of outcomes following operative intervention for spinal metastases. This allowed for advanced logistic regression testing that could effectively control for the presence of confounders such as patient age, medical comorbidities, nutritional and functional status, and the type of surgical intervention performed. The average age and demographics of patients included in this study, the number of complications encountered, as well as the mortality rate at 30 and 90 days are comparable to other works in the recent literature 3,5,8,10,12-14 and speak to the generalizability of our findings. Our final models were able to explain 85% of the variation in survival at 30 days and 76% of survival variation at 90 days following surgery. Overall, nutritional status, as measured by pre-operative serum albumin, was the most potent and consistent predictor. Patients with normal serum albumin levels (!3.5 g/dL) had odds of survival elevated by factors of 9 and 4 at 30 and 90 days, respectively, as compared with those with levels <3.5 g/dL (Figure 2 ; Tables 3 and 4 ). Serum albumin has been shown to influence the capacity to effect wound healing, along with total lymphocyte count and tissue oxygenation, in a number of orthopedic procedures including spine surgery and limb amputation. 11, 18 The recent study of Schoenfeld et al 11 showed that, among patients treated with spinal arthrodesis, low serum albumin resulted in greater odds of infection, venous thromboembolic disease, and mortality. The contribution of pre-operative nutritional status and overall physical health to survival following spinal surgery for metastatic disease may also be apparent in the findings regarding BMI, where those who were considered underweight demonstrated an 82% reduction in the odds of survival within 30 days of their surgical procedure. Normal ambulatory function before surgery was also an important predictor of survival, with the odds of survival increased 2 to 7-fold in the postoperative period for those with preserved ambulatory capacities as compared with patients with impaired function (Tables 3 and 4 ). Akin to our results for serum albumin, this is a relatively novel finding in the spine oncology literature. If viewed as a proxy for neurologic status, recent studies 8, 13 have not found such factors to be predictive of survival or postoperative outcomes. Nonetheless, it seems somewhat intuitive that patients with preserved ambulatory capacity would be able to mobilize to a greater extent following surgery and protect themselves from the development of complications that may contribute to early death, such as pneumonia or pulmonary embolism. 1, 14 Our results regarding the influence of primary tumor type on 90-day survival are not surprising. Patients in this analysis with metastatic lung cancer demonstrated a 64% reduction in the odds of survival at 90 days, synonymous with a number of efforts that have shown poor prognosis for patients with this type of cancer. 4, 5, 7, 8, 9, 12, 19, 20 Likewise, the more favorable outcomes for those with breast cancer and lymphoma/myeloma echo findings encountered in other works. 8 We employ caution in the interpretation of our determination regarding the influence of the type of surgery on postoperative survival. Although those individuals who received decompression in addition to spinal reconstruction had significantly greater odds of survival at 30 (OR 2.8; 95% CI 1.03-7.8) and 90 days (OR 2.6; 95% CI 1.3-5.2) than patients treated with decompression alone, we cannot rule out the fact that this variable is confounded by surgeons' estimations regarding a patient's capacity to survive the more complex and invasive reconstructive procedure. It is important to recognize that, as a retrospective work, clinical judgment regarding capacity to benefit from surgery among the included patients was made at the individual discretion of treating surgeons at 1 of the 4 participating centers over the course of the study period. No single clinical algorithm was used to inform the decision for surgery across all participating institutions. As a result, it is likely not appropriate to invest in these findings as a meaningful predictor for survival in the peri-operative period. This is but one of several limitations inherent to this work. In addition to our inability to control for selection and indication bias among treating physicians, this study suffers from limitations inherent to the retrospective design of the effort and reliance on registry data. We are limited to consider only those variables collected through the surgical registers and, thus, cannot speak to the role of surgeon experience, resident/fellow involvement, location of metastatic disease within the vertebral body, tumor histology, and the presence of hyperalgia. Because of these issues, we were unable to directly evaluate the predictive capacity of other tumor grading scales in our own study population. Tumor histology is known to influence decisions regarding approaches to management, including the aggressiveness of surgical intervention. 15, 16, 19, 20 For example, Bollen et al 19, 20 recently reported that metastatic spine tumors with favorable clinical profiles, inclusive of histology, were associated with improved survival rates following treatment. As a retrospective study, we were limited to the data imparted to the surgical registries at the participating centers. This did not include tumor histology to an extent such that we could reliably include this factor in our logistical models. This is a drawback of a multicenter retrospective work such as this, and we plan to redress this in future prospective work. Nonetheless, the impact of tumor histology on surgical decision making is potentially accounted for to some extent by our adjustments regarding the type of surgical intervention. A further limitation may lie in the fact that 3 of the 4 centers contributing patients to this analysis are located in a single American city, with 2 occupying virtually the same physical location and 2 serving as flagship hospitals of a major health care system. These facts may reduce the amount of clinical variation extant within these facilities and likely represent a form of clustering that could not be accounted for given the size of the sample and the statistical tests that were performed. Ultimately, the results of this work should be validated in independent samples before they can be widely embraced by the spine surgical community. Larger cohorts, with more substantial heterogeneity in terms of cancer diagnosis, may further elucidate the effect of other tumor types, such as prostate, renal, or gastrointestinal, on postsurgical mortality.
Despite these limitations, we seek to emphasize that the size of this study, multicenter focus, and advanced statistical approach mean that our findings represent some of the highest quality evidence available regarding patient-centered and surgical factors contributing to survival following operative intervention for spinal metastases. Results presented here suggest that medical interventions capable of optimizing nutritional and functional status before surgical intervention may return dividends in reduced postoperative mortality. At the same time, although primary tumor type is clearly not modifiable, patients with lung cancer as well as those with lymphoma/myeloma should be counseled regarding the influence that these diagnoses may have regarding survival in the first 90 days following surgery.
Key Points
This effort is one of the first to identify predictors of acute postoperative survival in a generalizable American population treated for spinal metastases. Cancer type did not influence the odds of survival at 30 days, while nutritional status and ambulatory capacity increased survival. Lung cancer significantly decreased the odds of survival at 90 days following surgery, while lymphoma/myeloma, ambulatory function, and nutritional status were associated with improved survival. Improved nutritional status and ambulatory function may enhance postoperative survival among individuals who undergo surgical intervention for spinal metastases.
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